FDA Okays Mauna Kea’s Updated Cellvizio Endomicroscopy System for GI Tracts

Mauna Kea Technologies has obtained FDA clearance for its updated Cellvizio endomicroscopy system for the GI and pulmonary tracts, according to a company release.

Advertisement

New features of the new Cellvizio 100 Series include improvements in endomicroscopic image acquisition and interpretation.

 

Used mainly in gastroenterology applications, Cellvizio provides real-time microscopic images of tissue inside the body.

 

Related Articles on FDA Clearances:

St. Jude Gets FDA Approval for Epiducer Neurostimulation Delivery System

B. Braun Receives FDA 510(k) Clearance for New DUPLEX System Use

FDA OKs Covidien’s Parietex Optimized Composite for Hernia Repair


At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Building a High-Performance Cardiac PET Program: What Health Systems Should Consider

Thursday, July 30
12:00 PM - 1:00 PM CDT

Presenters: Rupa Sanghani, MD, FACC, FASNC, Rush University Medical CenterBrendon Loiselle, CDL Nuclear Technologies

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.